Literature DB >> 19402227

Detection of silent cerebrovascular lesions in individuals with 'masked' and 'white-coat' hypertension by home blood pressure measurement: the Ohasama study.

Azusa Hara1, Takayoshi Ohkubo, Takeo Kondo, Masahiro Kikuya, Yoko Aono, Sugiko Hanawa, Kyoko Shioda, Sayaka Miyamoto, Taku Obara, Hirohito Metoki, Ryusuke Inoue, Kei Asayama, Takuo Hirose, Kazuhito Totsune, Haruhisa Hoshi, Shin-Ichi Izumi, Hiroshi Satoh, Yutaka Imai.   

Abstract

Objective To investigate the risk of silent cerebrovascular lesions in individuals with masked hypertension (MHT) and white-coat hypertension. Methods Self-measured home blood pressure (HBP) and casual blood pressure (CBP) measurements were recorded in 1060 individuals at least 55 years of age (mean age, 66.3 years) in a general population of Ohasama, Japan. The relationships between silent cerebrovascular lesions (white matter hyperintensity and lacunar infarct) detected on MRI and four blood pressure groups [sustained normal blood pressure (SNBP), HBP <135/85 mmHg, CBP <140/ 90 mmHg; white-coat hypertension, HBP <135/85 mmHg, CBP > or =140/90 mmHg; MHT, HBP > or =135/85 mmHg, CBP <140/90 mmHg; sustained hypertension, HBP > or =135/85 mmHg, CBP > or =140/90 mmHg] were examined using multivariate analysis adjusted for possible confounding factors. Results The odds ratios of sustained hypertension (1.74, 95% confidence interval 1.18-2.57) and MHT (2.31, 95% confidence interval 1.32-4.04) for the presence of silent cerebrovascular lesions were significantly higher than the odds ratio of SNBP, whereas there was no significant difference between white-coat hypertension and SNBP (1.03, 95% confidence interval 0.75-1.41). The odds ratios for the presence of either lacunar infarct or white matter hyperintensity in the four groups were similar to those for silent cerebrovascular lesions. Conclusion The present study is the first to demonstrate that the risk of silent cerebrovascular lesions is higher with MHT than with SNBP and similar to that of sustained hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19402227     DOI: 10.1097/hjh.0b013e3283298522

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis.

Authors:  Joji Ishikawa; Yukiko Ishikawa; Donald Edmondson; Thomas G Pickering; Joseph E Schwartz
Journal:  Blood Press Monit       Date:  2011-08       Impact factor: 1.444

Review 2.  A personal history of research on hypertension From an encounter with hypertension to the development of hypertension practice based on out-of-clinic blood pressure measurements.

Authors:  Yutaka Imai
Journal:  Hypertens Res       Date:  2022-09-08       Impact factor: 5.528

3.  Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study.

Authors:  Kazuomi Kario; Ikuo Saito; Toshio Kushiro; Satoshi Teramukai; Yusuke Ishikawa; Fumiaki Kobayashi; Kazuyuki Shimada
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-25       Impact factor: 3.738

4.  Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.

Authors:  K Kario; I Saito; T Kushiro; S Teramukai; Y Ishikawa; K Hiramatsu; F Kobayashi; K Shimada
Journal:  J Hum Hypertens       Date:  2013-07-18       Impact factor: 3.012

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.